On August 31, 2023, Dr. Lu Xianping, Chairman of Shenzhen Microchip Biotechnology Co., Ltd., visited our company for guidance and exchange. Our company attaches great importance to it. Huang Shenghong, a member of the Longgang District Political Consultative Conference and the main founder, chairman, and president of Sungening Biotechnology, gave a detailed introduction to Dr. Lu Xianping on the company's history, development plan, progress in innovative drug project research and development, and unique research and development platform from multiple perspectives.
Dr. Lu Xianping, Chairman of Microchip Biotech, stated that the main purpose of this visit is twofold: firstly, to understand the overall development of Sungening Biotech, especially the progress of new drug research and development; The second is to explore the possibility of collaboration between Microchip Biotech and Sungening Biotech in the development of new drugs. Dr. Lu Xianping highly recognizes Sungening Biotechnology's innovative and revenue generating dual drive development model, differentiated competition in research and development pipelines, and forward-looking research and development platforms.
As the first stock of the Science and Technology Innovation Board's biopharmaceutical conference, Microchip Biotechnology, led by Dr. Lu Xianping, has grown from an early innovative R&D enterprise to a leading modern biopharmaceutical enterprise in China that integrates early research and development of new drugs, clinical research and development, product development and production, pharmaceutical affairs and drug vigilance, product marketing, commercial and market access, and intellectual property rights. With core technology as the innovative R&D engine, rich original new drug product lines as the foundation, and sustainable development, it is a learning model for Sungening Biotechnology's future development.
